Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Colloid Interface Sci ; 544: 217-229, 2019 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-30849619

RESUMO

Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) (F127) hydrogels have been used to deliver nitric oxide (NO) topically in biomedical applications. Here, the effect of F127 microenvironments on the photochemical NO release from S-nitrosoglutathione (GSNO) was investigated in F127 solutions 7.6 wt% 15 wt% and 22.5 wt% at 15 °C and 37 °C. Small-angle X-ray Scattering (SAXS) and Differential Scanning Calorimetry (DSC) measurements, along with proton Nuclear Magnetic Resonance (1H NMR) spectral shifts and T2 relaxation data at six different concentration-temperature conditions, allowed identifying F127 microphases characterized by: a sol phase of unimers; micelles in non-defined periodic order, and a gel phase of cubic packed micelles. Kinetic measurements showed that GSNO photodecompositon proceeds faster in micellized F127 where GSNO is segregated to the intermicellar microenvironment. Real time kinetic monitoring of NO release and T2 relaxation profiles showed that NO is preferentially partitioned into the hydrophobic PPO cores of the F127 micelles, with the consequent decrease in its rate of release to the gas phase. These results show that F127 microphases affect both the kinetics of GSNO photodecomposition and the rate of NO escape and can be used to modulate the photochemical NO delivery from F127/GSNO solutions.


Assuntos
Hidrogéis/química , Óxido Nítrico/química , Poloxâmero/química , Polietilenoglicóis/química , Polímeros/química , Propilenoglicóis/química , S-Nitrosoglutationa/química , Portadores de Fármacos/química , Liberação Controlada de Fármacos , Cinética , Micelas , Processos Fotoquímicos , Temperatura
2.
Adv Healthc Mater ; 6(17)2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28699219

RESUMO

Enzyme prodrug therapy (EPT) enables localized conversion of inert prodrugs to active drugs by enzymes. Performance of EPT necessitates that the enzyme remains active throughout the time frame of the envisioned therapeutic application. ß-glucuronidase is an enzyme with historically validated performance in EPT, however it retains its activity in biomaterials for an insufficiently long period of time, typically not exceeding 7 d. Herein, the encapsulation of ß-glucuronidase in liposomal subcompartments within poly(vinyl alcohol) electrospun fibers is reported, leading to the assembly of biocatalytically active materials with activity of the enzyme sustained over at least seven weeks. It is further shown that liposomes provide the highly beneficial stabilization of the enzyme when incubated in cell culture media. The assembled biocatalytic materials successfully produce antiproliferative drugs (SN-38) using externally administered prodrugs (SN-38-glucuronide) and effectively suppress cell proliferation, with envisioned utility in the design of cardiovascular grafts.


Assuntos
Sistemas de Liberação de Medicamentos/métodos , Glucuronidase/metabolismo , Álcool de Polivinil/química , Pró-Fármacos/uso terapêutico , Biocatálise , Camptotecina/análogos & derivados , Camptotecina/farmacologia , Proliferação de Células/efeitos dos fármacos , Preparações de Ação Retardada , Estabilidade Enzimática , Células HeLa , Humanos , Irinotecano , Lipossomos/ultraestrutura , Tamanho da Partícula , Porosidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA